Phibro Animal Health Corp (PAHC) stock
PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$34.92−0.10 (-0.29%)
Close on Nov 17, 2026Market cap $1.42BP/E 14.4Yield 1.37%
Phibro Animal Health total assets
Total assets on the balance sheet at the end of each period.
Phibro Animal Health's total assets was $1.50B at Jun 30, 2026. For fiscal 2026 it was $1.50B, up 10.3% from the year before. Over ten years it grew 9.5% a year on average. The highest annual figure on record is $1.50B in fiscal 2026.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $1.50B | +10.3% |
| FY2025 | Jun 30, 2025 | $1.36B | +38.6% |
| FY2024 | Jun 30, 2024 | $982.18M | +1.1% |
| FY2023 | Jun 30, 2023 | $971.40M | +4.3% |
| FY2022 | Jun 30, 2022 | $931.70M | +10.7% |
| FY2021 | Jun 30, 2021 | $841.33M | +7.3% |
| FY2020 | Jun 30, 2020 | $784.10M | +7.9% |
| FY2019 | Jun 30, 2019 | $726.67M | +8.2% |
| FY2018 | Jun 30, 2018 | $671.68M | +7.7% |
| FY2017 | Jun 30, 2017 | $623.40M | +2.6% |
| FY2016 | Jun 30, 2016 | $607.84M | +23.2% |
| FY2015 | Jun 30, 2015 | $493.32M | +4.4% |
| FY2014 | Jun 30, 2014 | $472.32M | -0.4% |
| FY2013 | Jun 30, 2013 | $474.14M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $1.50B | +10.3% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $1.45B | +9.7% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $1.41B | +9.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $1.39B | +43.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $1.36B | +38.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $1.32B | +34.5% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $1.29B | +32.2% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $966.29M | +0.2% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $982.18M | +1.1% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $979.04M | +1.4% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $972.71M | +1.1% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $964.52M | +1.7% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $971.40M | +4.3% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $965.43M | +5.4% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $961.83M | +13.3% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $948.38M | +13.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $931.70M | +10.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $916.18M | +13.8% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $848.96M | +5.6% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $836.04M | +5.9% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $841.33M | +7.3% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $805.02M | +3.7% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $803.65M | +1.9% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $789.55M | -0.7% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $784.10M | +7.9% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $776.05M | +9.9% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $788.32M | +13.1% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $795.24M | +17.2% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $726.67M | +8.2% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $706.42M | +5.3% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $697.29M | +5.2% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $678.48M | +1.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $671.68M | +7.7% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $670.84M | +11.4% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $663.13M | +12.0% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $671.11M | +12.2% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $623.40M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $602.28M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $592.29M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $598.08M | – |
See a number that looks wrong?